Keyphrases
1p Deletion
25%
3p Deletion
25%
Aberrations
28%
Acute Lymphoblastic Leukemia
30%
Acute Myeloid Leukemia
25%
Alkylating Agents
25%
CALM-AF10
25%
Catalytic Domain
25%
Children's Oncology Group
31%
Chromosomal Abnormalities
53%
Clinical Diagnostic Laboratory
25%
Comparative Genomic Hybridization
50%
Copy number Variation
25%
Cytogenetic Characterization
25%
Etoposide
37%
ETV6
56%
ETV6-NTRK3 Fusion
25%
Familial Medullary Thyroid Carcinoma
30%
Fluorescence in Situ Hybridization
42%
Fusion Product
31%
Genetic Abnormalities
25%
Genetic Loci
41%
Genome Resources
25%
Group Studies
33%
Hematological Malignancies
75%
Hematopathology
25%
Human Chromosomes
25%
Infantile Fibrosarcoma
25%
Inv(11)(q21q23)
25%
Karyotype Analysis
25%
Medullary Thyroid Carcinoma
33%
Meningioma
25%
Mitoxantrone
33%
Molecular Characterization
25%
Molecular Cytogenetics
25%
Multiple Endocrine Neoplasia Type 2 (MEN2)
70%
Myoepithelial Carcinoma
25%
Neurofibromatosis Type I
25%
Post-transplant Lymphoproliferative Disorder
25%
Primary Induction Failure
25%
Receptor Tyrosine Kinase
30%
Recurring
32%
Relapsed or Refractory Acute Myeloid Leukemia
25%
RET Proto-oncogene
50%
Spectral Karyotyping
56%
T Cells
35%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
50%
Tumor
30%
Tyrosine Kinase
31%
Yeast Artificial Chromosome
25%
Biochemistry, Genetics and Molecular Biology
Allele
48%
B Cell
30%
Carcinogenesis
15%
Cell Proliferation
8%
Centromere
12%
Chromosomal Abnormalities
44%
Chromosomal Disorder
25%
Chromosome 10
10%
Chromosome 11
10%
Chromosome 22
25%
Chromosome Analysis
11%
Chromosome Rearrangement
12%
Comparative Genomic Hybridization
25%
Contig
25%
Cyclophosphamide
10%
Cytogenetics
50%
Enzyme Active Site
25%
Epstein Barr Virus
8%
ETV6
50%
Exon
28%
Fluorescence in Situ Hybridization
45%
Fusion Transcript
35%
Gene Locus
41%
Genetics
63%
Genotype Phenotype Correlation
25%
Germ Cell
33%
Heterozygosity
12%
Human Chromosome
25%
Karyotype
30%
Karyotyping
25%
KMT2A
25%
Kruppel Like Factor
25%
Ligand Binding Domain
8%
Medical Genetics
25%
Missense Mutation
25%
Morphology
30%
Myeloid
50%
Offspring
25%
Point Mutation
38%
Proto Oncogene
25%
Receptor Tyrosine Kinase
55%
RET Proto-Oncogene
25%
Reverse Transcription Polymerase Chain Reaction
10%
Sex Ratio
25%
Spectral Karyotyping
55%
T Cell
100%
TFE3
25%
Trisomy 9
16%
Tyrosine Kinase
30%
Yeast Artificial Chromosome
25%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
50%
Acute Myelogenous Leukemia
37%
Acute Myeloid Leukemia
81%
Alkylating Antineoplastic Agent
25%
Allele
17%
B Cell
10%
Cell Line
25%
Chromosome 11
11%
Chromosome Aberration
25%
Clear Cell Renal Cell Carcinoma
25%
Clinical Management
11%
Comparative Genomic Hybridization
25%
Cyclophosphamide
12%
Cytarabine
25%
Cytostatic Agent
12%
Disease
11%
Diseases
16%
Drug Resistance
12%
Drug-Resistant Cell Line
25%
Etoposide
37%
Exon
25%
Fibrosarcoma
25%
GAB2
16%
Gene Expression
16%
Hematologic Malignancy
25%
Hematopathology
25%
Hemophagocytic Syndrome
25%
Kidney Tumour
33%
Kruppel Like Factor
25%
Leukemia
10%
Leukemogenesis
11%
Mediator
25%
Mitoxantrone
31%
Molecular Diagnosis
25%
Multiple Endocrine Neoplasia Type 2a
10%
Myelodysplastic Syndrome
12%
Myeloid Leukemia
15%
Myeloid Malignancy
25%
Myoepithelial Carcinoma
25%
Neoplasm
50%
Neurofibromatosis Type I
25%
Oncology
29%
Pediatrics
31%
Posttransplant Lymphoproliferative Disease
25%
Protein Tyrosine Kinase
30%
Proto Oncogene
25%
T Cell
42%
T Lymphocyte
25%
Thyroid Medullary Carcinoma
25%
Trisomy
10%